Literature DB >> 18590462

Drug-eluting polymer implants in cancer therapy.

Agata A Exner1, Gerald M Saidel.   

Abstract

BACKGROUND: Drug-eluting polymer implants present a compelling parenteral route of administration for cancer chemotherapy. With potential for minimally invasive, image-guided placement and highly localized drug release, these delivery systems are playing an increasingly important role in cancer management. This is particularly true as the use of labile proteins and other bioactive molecules is likely to increase in the upcoming years.
OBJECTIVE: In this review, we present the current trends in the application of Pre-formed and in situ-forming systems as drug-eluting implants for cancer chemotherapy.
METHODS: We outline the clinically available options as well as up-and-coming technologies and their advantages and challenges. We also describe ongoing related innovations with image-guided drug delivery, mathematical modeling of implanted delivery systems and implanted drug delivery in combination with other therapies. RESULTS/
CONCLUSION: Whether used alone or combined with other minimally invasive procedures, drug-eluting polymeric implants will play a significant role in the future of cancer management.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590462     DOI: 10.1517/17425247.5.7.775

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  18 in total

1.  3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.

Authors:  Stefan T Yohe; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2012-06-06       Impact factor: 9.776

2.  The Effect of Additives on the Behavior of Phase Sensitive In Situ Forming Implants.

Authors:  Luis Solorio; Divya Sundarapandiyan; Alex Olear; Agata A Exner
Journal:  J Pharm Sci       Date:  2015-07-14       Impact factor: 3.534

Review 3.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

Review 4.  Bioavailability of phytochemicals and its enhancement by drug delivery systems.

Authors:  Farrukh Aqil; Radha Munagala; Jeyaprakash Jeyabalan; Manicka V Vadhanam
Journal:  Cancer Lett       Date:  2013-02-19       Impact factor: 8.679

5.  Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.

Authors:  Luis Solorio; Hanping Wu; Christopher Hernandez; Mihika Gangolli; Agata A Exner
Journal:  Ther Deliv       Date:  2016

6.  Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.

Authors:  Ravi B Patel; Angela N Carlson; Luis Solorio; Agata A Exner
Journal:  J Biomed Mater Res A       Date:  2010-08       Impact factor: 4.396

7.  Noninvasive characterization of in situ forming implant diffusivity using diffusion-weighted MRI.

Authors:  Kelsey A Hopkins; Nicole Vike; Xin Li; Jacqueline Kennedy; Emma Simmons; Joseph Rispoli; Luis Solorio
Journal:  J Control Release       Date:  2019-07-16       Impact factor: 9.776

Review 8.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.

Authors:  Jesse B Wolinsky; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

9.  Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging.

Authors:  Luis Solorio; Alexander M Olear; Haoyan Zhou; Ashlei C Beiswenger; Agata A Exner
Journal:  Drug Deliv Transl Res       Date:  2012-02-01       Impact factor: 4.617

10.  Noninvasive characterization of in situ forming implants using diagnostic ultrasound.

Authors:  Luis Solorio; Brett M Babin; Ravi B Patel; Justyna Mach; Nami Azar; Agata A Exner
Journal:  J Control Release       Date:  2010-01-11       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.